TAK FCF Yield: current value, 10-year range and year-by-year history
Cash & Leverage
TAK's fcf yield is right around its 10-year median of 6.7%.
FCF Yield History
TAK FCF Yield by year
Yearly range of TAK’s fcf yield from 2016 to 2026. Over the full period it ranged from -2.9% to 18.3%, averaging 7.3%.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 6.0% | 6.3% | 6.7% | 6.2% |
| 2025 | 10.7% | 12.0% | 13.5% | 11.0% |
| 2024 | -2.0% | 4.9% | 13.1% | 13.1% |
| 2023 | 1.8% | 5.3% | 12.9% | 2.1% |
| 2022 | 12.1% | 14.7% | 18.2% | 12.3% |
| 2021 | 8.9% | 13.2% | 18.3% | 18.3% |
| 2020 | 5.8% | 7.7% | 10.3% | 10.3% |
| 2019 | 2.7% | 5.1% | 7.8% | 6.0% |
| 2018 | 4.3% | 6.0% | 8.1% | 7.6% |
| 2017 | -2.9% | 1.9% | 3.6% | 3.1% |
| 2016 | -1.1% | -0.9% | -0.3% | -1.1% |
Free cash flow generated divided by market capitalisation. Often more reliable than earnings yield because it reflects actual cash — harder to inflate through accounting choices.
Free Cash Flow / Market Cap × 100%Think of it as the "cash earnings yield" on your investment. High FCF yield vs history suggests the market may be undervaluing the company's real cash generation ability.
- FCF can be lumpy year-to-year due to irregular capex or working capital swings. Look at 3–5 year trends, not single-year readings.
- Businesses intentionally reinvesting for growth will show low or negative FCF yield by design — this metric is less useful for high-growth phase companies.
Is TAK FCF Yield High or Low Right Now?
Takeda Pharmaceutical Company Limited's FCF Yield is currently 6.2%, which is around average relative to its 10-year historical range. The 10-year median FCF Yield for TAK is approximately 6.7%. See all TAK valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.